SAN FRANCISCO--(BUSINESS WIRE)--In 2024, Unlearn ® achieved key milestones in advancing AI to eliminate trial and error in medicine. From securing $50M in Series C ...

Before I went through personal development, I was closed-minded. Negative. Jealous. Thought I knew better. I thought that successful people were just lucky. That I was born less privileged than the ...

Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...

Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with ...

Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...

Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

While it is true that experiences are an indispensable part of learning to start a venture, we must not forget that focusing an idea on innovation and not on established paradigms can be much more ...

One summer in college I canvassed for a local non-profit. We went door to door telling people about the organization and asking them to sign various petitions. I recited my spiel a hundred times. “Hi, ...

While a lot of learning happens at Calvin University in any given week, the week of October 30—November 6, 2023, takes a different twist. Jane Bruin, director of the center for intercultural student ...